| Gene symbol | TGFB2 | Synonyms | G-TSF, LDS4, TGF-beta2 | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1q41 | dbXrefs | |
| Description | transforming growth factor beta 2 | ||||
| GTO ID | GTC2674 |
| Trial ID | NCT04862767 |
| Disease | Solid Tumor |
| Altered gene | TGFB2 |
| Therapeutic/Target gene | Target gene |
| Therapy | ASO |
| Treatment | TASO-001 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Multi-center, Open Label, Phase Ib Clinical Trial to Evaluate Safety, Tolerance and Efficacy of TASO(TGF-β2 Targeting Anti-sense Oligonucleotide)-001 in Combination With Recombinant Interleukin-2 in Advanced or Metastatic Solid Tumor |
| Year | 2021 |
| Country | Korea,Republic of |
| Company sponsor | Autotelicbio |
| Other ID(s) | ATB-301-001 |
| Vector information | |||
|
|||
| Cohort 1 | |||||
|
|||||